Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06297993 · ClinicalTrials.gov registry record
Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study)
A clinical trial of PSC, sponsored by PSC Partners Seeking a Cure.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 16
- Study locations
NCT06297993: Recruiting study of PSC, sponsored by PSC Partners Seeking a Cure.
NCT06297993 is a study of PSC that is actively recruiting participants, run by PSC Partners Seeking a Cure. The registered enrollment target is 2,000 participants. The trial reports 16 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06297993, a study of PSC, is actively recruiting participants, sponsored by PSC Partners Seeking a Cure.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 16
- Study locations
Study Summary
Develop an appropriate real-world data comparator cohort to support the design, execution, and serve as an external control for interventional clinical trials in PSC.
Primary Outcome
Collection of liver-related data including PSC symptoms, medical history, adverse events, and outcomes at enrollment and each quarterly and annual visit.
Conditions Studied
Study Locations (16)
California
- UC Davis - Sacramento
- California Pacific Medical Center - San Francisco
- University of California, San Francisco - San Francisco
Massachusetts
- Massachusetts General Hospital - Boston
- Beth Israel Deaconess Medical Center - Boston
Connecticut
- Yale University - New Haven
Florida
- Schiff Center for Liver Diseases / University of Miami - Miami
Indiana
- Indiana University - Indianapolis
Minnesota
- Mayo Clinic - Rochester
Virginia
- Virginia Commonwealth University - Richmond
Alberta
- University of Alberta - Edmonton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2024-05-06 |
| Est. Completion | 2031-01 |
What NCT06297993 shows while recruiting
NCT06297993 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with PSC appearing as the primary indexed condition, and to 0 interventions.
NCT06297993 lists 16 locations in 13 states (California, Massachusetts, Connecticut).
Frequently Asked Questions
What is clinical trial NCT06297993 about?
NCT06297993 is a clinical study titled "Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study)". Develop an appropriate real-world data comparator cohort to support the design, execution, and serve as an external control for interventional clinical trials in PSC.
What is the current status of trial NCT06297993?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2024-05-06. Estimated completion is 2031-01.
What conditions does trial NCT06297993 study?
This clinical trial studies the following conditions: PSC.
Who is sponsoring clinical trial NCT06297993?
This trial is sponsored by PSC Partners Seeking a Cure, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06297993 being conducted?
This trial has 16 study locations across California, Connecticut, Florida, Indiana, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PSC
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI